Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
The Journal of Sexual Medicine
|
May 29, 2009
Expression of caveolin-1 in penile cavernosal tissue in a denervated animal model after treatment with sildenafil citrate
Edgardo F Becher, Jorge E Toblli, Cynthia Castronuovo, et al.
Biomolecules
|
July 10, 2020
Myxovirus Resistance Protein 1 (MX1), a Novel HO-1 Interactor, Tilts the Balance of Endoplasmic Reticulum Stress towards Pro-Death Events in Prostate Cancer
Emiliano Ortiz, Pablo Sanchis, Juan Bizzotto, et al.
FEBS Letters
|
May 31, 2021
The pluripotency transcription factor OCT4 represses heme oxygenase-1 gene expression
María Victoria Petrone, Ayelén Toro, Camila Vazquez Echegaray, et al.
Oncotarget
|
April 9, 2016
Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse
Daiana B Leonardi, Mercedes Abbate, María C Riccheri, et al.
Bone
|
December 17, 2011
Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth
Xinhai Wan, Zhi-Gang Li, Jonathan M Yingling, et al.
Frontiers in Pharmacology
|
December 3, 2025
Genetic characterization of pediatric B-cell acute lymphoblastic leukemia in Argentina uncovers molecular heterogeneity and novel variants
María Sol Ruiz, Ezequiel Sosa, Daniel Avendaño, et al.
Oncotarget
|
February 22, 2018
High RAC3 expression levels are required for induction and maintaining of cancer cell stemness
Laura C Panelo, Mileni Soares Machado, María F Rubio, et al.
Iscience
|
September 29, 2020
SARS-CoV-2 Infection Boosts <i>MX1</i> Antiviral Effector in COVID-19 Patients
Juan Bizzotto, Pablo Sanchis, Mercedes Abbate, et al.
Current Pharmaceutical Biotechnology
|
November 9, 2019
Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer
Florencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Current Pharmaceutical Biotechnology
|
April 11, 2015
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer
Florencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
The Journal of Sexual Medicine
|
May 29, 2009
Expression of caveolin-1 in penile cavernosal tissue in a denervated animal model after treatment with sildenafil citrate
Edgardo F Becher, Jorge E Toblli, Cynthia Castronuovo, et al.
Biomolecules
|
July 10, 2020
Myxovirus Resistance Protein 1 (MX1), a Novel HO-1 Interactor, Tilts the Balance of Endoplasmic Reticulum Stress towards Pro-Death Events in Prostate Cancer
Emiliano Ortiz, Pablo Sanchis, Juan Bizzotto, et al.
FEBS Letters
|
May 31, 2021
The pluripotency transcription factor OCT4 represses heme oxygenase-1 gene expression
María Victoria Petrone, Ayelén Toro, Camila Vazquez Echegaray, et al.
Oncotarget
|
April 9, 2016
Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse
Daiana B Leonardi, Mercedes Abbate, María C Riccheri, et al.
Bone
|
December 17, 2011
Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth
Xinhai Wan, Zhi-Gang Li, Jonathan M Yingling, et al.
Frontiers in Pharmacology
|
December 3, 2025
Genetic characterization of pediatric B-cell acute lymphoblastic leukemia in Argentina uncovers molecular heterogeneity and novel variants
María Sol Ruiz, Ezequiel Sosa, Daniel Avendaño, et al.
Oncotarget
|
February 22, 2018
High RAC3 expression levels are required for induction and maintaining of cancer cell stemness
Laura C Panelo, Mileni Soares Machado, María F Rubio, et al.
Iscience
|
September 29, 2020
SARS-CoV-2 Infection Boosts <i>MX1</i> Antiviral Effector in COVID-19 Patients
Juan Bizzotto, Pablo Sanchis, Mercedes Abbate, et al.
Current Pharmaceutical Biotechnology
|
November 9, 2019
Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer
Florencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Current Pharmaceutical Biotechnology
|
April 11, 2015
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer
Florencia Zalazar, Paola De Luca, Kevin Gardner, et al.
Page
of 4